Basic scientists at the Indiana University School of Medicine conduct leading-edge research on the neurobiology and molecular genetics of Alzheimer’s disease to define disease mechanisms using animal models and cellular, identify therapeutic targets, rigorously test drugs using preclinical testing protocols, and create molecules for potential drugs. Researchers span several departments at the IU School of Medicine and collaborate on their investigations and grant-funded research through the Stark Neurosciences Research Institute. Investigators who lead multiple federally-funded grant programs work in tandem to advance discoveries in Alzheimer's research.
MODEL-AD
The MODEL-AD consortium develops better animal models used by scientists throughout the United States to study contributors to Alzheimer’s disease and test potential treatments.
TREAT-AD
Researchers in the TREAT-AD center search for new therapeutic targets and molecules to accelerate the development of promising new drugs for Alzheimer’s disease.
MPS-AD
The MPS-AD center develops brain organoids to study characteristics of Alzheimer’s disease. Researchers lead preclinical and pharmacological studies to accelerate drug discovery.
Basic science experts
Bruce T. Lamb, PhD
Executive Director, Paul and Carole Stark Neurosciences Research Institute
Donna M. Wilcock, PhD
Barbara and Larry Sharpf Professor of Alzheimer's Disease Research
Interview an Alzheimer's Disease Expert
Schedule an interview with an IU School of Medicine faculty member or request materials and resources about Alzheimer’s disease research by contacting the IU School of Medicine media relations team.